Skip to main content
. 2023 Jan 16;10:1037157. doi: 10.3389/fpubh.2022.1037157

Figure 5.

Figure 5

Estimated global PDR for MR-MAPs from 2030 to 2040 by use case. PDR, programmatic doses required; MR, measles and rubella; MAPs, microarray patches; UC, use case; HW, health worker; and CHW, community health worker.